EnteroBiotix: EnteroBiotix reports positive results from TrIuMPH phase 2a trial of EBX10202 in adults with irritable bowel syndrome with constipation
EnteroBiotix Limited, a clinical─stage biopharmaceutical company focussed on developing best─in─class drugs for gut health, today announced positive initial results with EBX─102─02, the company's next─
Read full article »
EnteroBiotix is a Scotland-based biotechnology company that researches and develops novel microbiome-modulating therapeutics for the treatment of bacterial infections.
Read more